Skip to content
On this page:OverviewPublicationsResearchersInstitutionsOpen access
PICO Portalanswers from OpenAlex

University of Toledo

InstitutionResearch output, impact & collaborations

University of Toledo is a institution indexed in PICO Portal from OpenAlex.

What is known about University of Toledo?

PICO Portalrecord summary

University of Toledo is a research organisation in Toledo, US. OpenAlex records 46,735 works and 2,359,479 citations for it. 9,868 researchers list it as their most recent affiliation.

How many works does University of Toledo have?

PICO Portalindexed works

University of Toledo has 46,735 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does University of Toledo have?

PICO Portalcitation count

University of Toledo has 2,359,479 citations in the OpenAlex counts PICO Portal stores.

How many researchers are at University of Toledo?

PICO Portalresearcher count

University of Toledo has 9,868 researchers in the PICO Portal index.

What is the average h-index at University of Toledo?

PICO Portalavg h-index

University of Toledo has an average h-index of 65.8 in OpenAlex.

What is the ROR of University of Toledo?

PICO Portalror

The ROR for University of Toledo is on the source record.

What is the OpenAlex record for University of Toledo?

PICO Portalopenalex

The OpenAlex for University of Toledo is on the source record.

Who are the most-cited researchers behind University of Toledo?

PICO Portaltop researchers by citations
1
Yanfa Yan · Chalcogenide Semiconductor Thin Films
898 works68,128 citations
2
Aidin Abedi · Urinary Bladder and Prostate Research
151 works41,920 citations
3
Kim L. Gratz · Suicide and Self-Harm Studies
308 works30,845 citations
4
Eunice L. Kwak · Colorectal Cancer Treatments and Studies
279 works29,614 citations
5
Jon D. Elhai · Posttraumatic Stress Disorder Research
596 works28,702 citations

What are the most-cited papers on University of Toledo?

PICO Portalmost cited works
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge, Alice T. Shaw, Benjamin Solomon, Robert G. Maki, Sai‐Hong Ignatius Ou, Bruce J. Dezube, Pasi A. Jänne, Daniel B. Costa, Marileila Varella‐Garcia, Woo Ho Kim, Thomas J. Lynch, Panos Fidias, Hannah Stubbs, Jeffrey A. Engelman, Lecia V. Sequist, Weiwei Tan, Leena Gandhi, Mari Mino–Kenudson, Greg C. G. Wei, S. Martin Shreeve, Mark J. Ratain, Jeffrey Settleman, James G. Christensen, Daniel A. Haber, Keith D. Wilner, Ravi Salgia, Geoffrey I. Shapiro, Jeffrey W. Clark, A. John Iafrate
New England Journal of Medicine. 20104,513 Citations
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath, Lecia V. Sequist, Shyamala Maheswaran, Daphne W. Bell, Daniel Irimia, Lindsey Ulkus, Matthew R. Smith, Eunice L. Kwak, Subba R. Digumarthy, Alona Muzikansky, Paula D. Ryan, Ulysses J. Balis, Ronald G. Tompkins, Daniel A. Haber, Mehmet Toner
Nature. 20073,549 CitationsOPEN ACCESS
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor <i>EML4-ALK</i>
Alice T. Shaw, Beow Y. Yeap, Mari Mino–Kenudson, Subba R. Digumarthy, Daniel B. Costa, Rebecca S. Heist, Benjamin Solomon, Hannah Stubbs, Sonal Admane, Ultan McDermott, Jeffrey Settleman, Susumu Kobayashi, Eugene J. Mark, Scott J. Rodig, Lucian R. Chirieac, Eunice L. Kwak, Thomas J. Lynch, A. John Iafrate
Journal of Clinical Oncology. 20091,889 CitationsOPEN ACCESS
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
Kristin Bergethon, Alice T. Shaw, Sai‐Hong Ignatius Ou, Ryohei Katayama, Christine M. Lovly, Nerina T. McDonald, Pierre P. Massion, Christina T. Siwak-Tapp, Adriana González, Rong Fang, Eugene J. Mark, Julie M. Batten, Haiquan Chen, Keith D. Wilner, Eunice L. Kwak, Jeffrey W. Clark, David P. Carbone, Hongbin Ji, Jeffrey A. Engelman, Mari Mino–Kenudson, William Pao, A. John Iafrate
Journal of Clinical Oncology. 20121,563 CitationsOPEN ACCESS
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
D. Ross Camidge, Yung‐Jue Bang, Eunice L. Kwak, A. John Iafrate, Marileila Varella‐Garcia, Stephen B. Fox, Gregory J. Riely, Benjamin Solomon, Sai‐Hong Ignatius Ou, Dong‐Wan Kim, Ravi Salgia, P. Fidias, Jeffrey A. Engelman, Leena Gandhi, Pasi A. Jänne, Daniel B. Costa, Geoffrey I. Shapiro, Patricia LoRusso, Katherine Ruffner, Patricia Stephenson, Yiyun Tang, Keith D. Wilner, Jeffrey W. Clark, Alice T. Shaw
The Lancet Oncology. 20121,283 Citations

How much of the research on University of Toledo is open access?

PICO Portalopen access share
67%OPEN ACCESS
Gold
8%
Green
17%
Hybrid
0%
Bronze
42%
Closed
33%

Related on PICO Portal

470M+ articles · 14-day free trial